Breast Imaging Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Breast Imaging Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

The breast is made up of glands called lobules that are capable of producing milk. This milk is carried through thin tubes called ducts to the lobules or the nipples. The breast tissue also contains fat and connective tissue as well as blood vessels and lymph nodes. Thus breast imaging is the technique that used to examine the breast by providing the detailed representation of it on computer for lumps or changes in size or shape. Hence, this technique aid in the early detection and diagnosis of breast cancer.
Market Dynamics
Upsurge in prevalence of breast cancer is anticipated to fuel growth of the breast imaging market. Breast cancer can occur both in men and women. It is majorly reported in females as compared to men. According to the National Cancer Institute, around 100 times more new cases of breast cancer were reported in women than in men annually.
Furthermore, According to the National Cancer Foundation (NBCF), breast cancer is the second most diagnosed cancer worldwide, which accounts for 10.9% of cancer incidences in both men and women. The NBCF estimated that 2,470 men will be diagnosed with breast cancer and around 460 will die annually.
Moreover, supportive government initiatives such UK government campaign’s ‘Be clear on cancer,’ helped in spreading awareness about the risk factors, preventive measures, and early diagnosis of cancer. This campaign also include free screening programs, which helped in diagnosing around 15,000 cancer patients. Thus, provides huge opportunities for adoption of breast imaging products by various hospitals during the forecast period.
Key features of the study:

This report provides in-depth analysis of the breast imaging market, market size (US$ Mn) and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global breast imaging market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Hologic, Inc., General Electric Company, Siemens AG, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc., and Dilon Technologies, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global breast imaging market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for breast imaging market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Breast Imaging Market, By Technology:

Ionizing Breast Imaging Technology

Analog Mammography
Full Field Digital Mammography (FFDM)
3D Breast Tomosynthesis
Positron Emission Tomography/ Computed Tomography (PET/CT)
Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI)
Positron Emission Mammography
Others

Non-Ionizing Breast Imaging Technology

Breast MRI (Magnetic Resonance Imaging)
Breast Ultrasound
Optical Imaging
Automated Whole Breast Ultrasound (AWBU)
Breast Thermography

Global Breast Imaging Market, By End User:

Hospitals
Diagnostic Laboratories
Ambulatory Surgical Centers

Global Breast Imaging Market, By Region:

North America

By Country:

U.S.
Canada

By Technology:

Ionizing Breast Imaging Technology

Analog Mammography
Full Field Digital Mammography (FFDM)
3D Breast Tomosynthesis
Positron Emission Tomography/ Computed Tomography (PET/CT)
Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI)
Positron Emission Mammography
Others

Non-Ionizing Breast Imaging Technology

Breast MRI (Magnetic Resonance Imaging)
Breast Ultrasound
Optical Imaging
Automated Whole Breast Ultrasound (AWBU)
Breast Thermography

By End User:

Hospitals
Diagnostic Laboratories
Ambulatory Surgical Centers

Europe

By Country:

U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe

By Technology:

Ionizing Breast Imaging Technology

Analog Mammography
Full Field Digital Mammography (FFDM)
3D Breast Tomosynthesis
Positron Emission Tomography/ Computed Tomography (PET/CT)
Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI)
Positron Emission Mammography
Others

Non-Ionizing Breast Imaging Technology

Breast MRI (Magnetic Resonance Imaging)
Breast Ultrasound
Optical Imaging
Automated Whole Breast Ultrasound (AWBU)
Breast Thermography

By End User:

Hospitals
Diagnostic Laboratories
Ambulatory Surgical Centers

Asia Pacific

By Country:

Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific

By Technology:

Ionizing Breast Imaging Technology

Analog Mammography
Full Field Digital Mammography (FFDM)
3D Breast Tomosynthesis
Positron Emission Tomography/ Computed Tomography (PET/CT)
Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI)
Positron Emission Mammography
Others

Non-Ionizing Breast Imaging Technology

Breast MRI (Magnetic Resonance Imaging)
Breast Ultrasound
Optical Imaging
Automated Whole Breast Ultrasound (AWBU)
Breast Thermography

By End User:

Hospitals
Diagnostic Laboratories
Ambulatory Surgical Centers

Latin America

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

By Technology:

Ionizing Breast Imaging Technology

Analog Mammography
Full Field Digital Mammography (FFDM)
3D Breast Tomosynthesis
Positron Emission Tomography/ Computed Tomography (PET/CT)
Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI)
Positron Emission Mammography
Others

Non-Ionizing Breast Imaging Technology

Breast MRI (Magnetic Resonance Imaging)
Breast Ultrasound
Optical Imaging
Automated Whole Breast Ultrasound (AWBU)
Breast Thermography

By End User:

Hospitals
Diagnostic Laboratories
Ambulatory Surgical Centers

Middle East

By Country:

GCC
Israel
Rest of Middle East

By Technology:

Ionizing Breast Imaging Technology

Analog Mammography
Full Field Digital Mammography (FFDM)
3D Breast Tomosynthesis
Positron Emission Tomography/ Computed Tomography (PET/CT)
Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI)
Positron Emission Mammography
Others

Non-Ionizing Breast Imaging Technology

Breast MRI (Magnetic Resonance Imaging)
Breast Ultrasound
Optical Imaging
Automated Whole Breast Ultrasound (AWBU)
Breast Thermography

By End User:

Hospitals
Diagnostic Laboratories
Ambulatory Surgical Centers

Africa

By Country:

South Africa
Central Africa
North Africa

By Technology:

Ionizing Breast Imaging Technology

Analog Mammography
Full Field Digital Mammography (FFDM)
3D Breast Tomosynthesis
Positron Emission Tomography/ Computed Tomography (PET/CT)
Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI)
Positron Emission Mammography
Others

Non-Ionizing Breast Imaging Technology

Breast MRI (Magnetic Resonance Imaging)
Breast Ultrasound
Optical Imaging
Automated Whole Breast Ultrasound (AWBU)
Breast Thermography

By End User:

Hospitals
Diagnostic Laboratories
Ambulatory Surgical Centers

Company Profiles

Hologic, Inc. *

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

General Electric Company
Siemens AG
Koninklijke Philips N.V.
Fujifilm Holdings Corporation
Gamma Medica, Inc.
Toshiba Corporation
Sonocine, Inc.
Aurora Imaging Technology, Inc.
Dilon Technologies, Inc.

“*” marked represents similar segmentation in other categories in the respective section.